WHO Essential Medicines List and methylphenidate for ADHD in children and adolescents

Ole Jakob Storebø; Johanne Pereira Ribeiro; Charlotte Lunde; Christian Gluud

doi:10.1016/S2215-0366(23)00395-4

WHO Essential Medicines List and methylphenidate for ADHD in children and adolescents

Ole Jakob Storebø^*
, Johanne Pereira Ribeiro
, Charlotte Lunde
, Christian Gluud

^*Kontaktforfatter

University of Oslo
Psychiatry Region Zealand
Rigshospitalet

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	The Lancet Psychiatry
Vol/bind	11
Udgave nummer	2
Sider (fra-til)	93
Antal sider	1
ISSN	2215-0366
DOI	https://doi.org/10.1016/S2215-0366(23)00395-4
Status	Udgivet - feb. 2024

Dokumenter og links

10.1016/S2215-0366(23)00395-4

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

@article{20c01be4d1524412906210c35f83eee5,

title = "WHO Essential Medicines List and methylphenidate for ADHD in children and adolescents",

keywords = "Adolescent, Attention Deficit Disorder with Hyperactivity/drug therapy, Central Nervous System Stimulants/therapeutic use, Child, Humans, Methylphenidate/therapeutic use, World Health Organization",

author = "Storeb{\o}, \{Ole Jakob\} and Ribeiro, \{Johanne Pereira\} and Charlotte Lunde and Christian Gluud",

year = "2024",

month = feb,

doi = "10.1016/S2215-0366(23)00395-4",

language = "English",

volume = "11",

pages = "93",

journal = "The Lancet Psychiatry",

issn = "2215-0366",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - WHO Essential Medicines List and methylphenidate for ADHD in children and adolescents

AU - Storebø, Ole Jakob

AU - Ribeiro, Johanne Pereira

AU - Lunde, Charlotte

AU - Gluud, Christian

PY - 2024/2

Y1 - 2024/2

KW - Adolescent

KW - Attention Deficit Disorder with Hyperactivity/drug therapy

KW - Central Nervous System Stimulants/therapeutic use

KW - Child

KW - Humans

KW - Methylphenidate/therapeutic use

KW - World Health Organization

U2 - 10.1016/S2215-0366(23)00395-4

DO - 10.1016/S2215-0366(23)00395-4

M3 - Comment/debate

C2 - 38245023

AN - SCOPUS:85182794513

SN - 2215-0366

VL - 11

SP - 93

JO - The Lancet Psychiatry

JF - The Lancet Psychiatry

IS - 2

ER -